Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Teriparatide to reduce risk of loosening after total knee replacement
2009-011784-37Phase 4Completed
- Sponsor
- Department of Orthopaedics
- Start
- Aug 2009
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of teriparatide in knee osteoarthritis (OA) (2 arms), sponsored by Department of Orthopaedics. Primary endpoint: Tibial component migration by RSA. Started Aug 2009; status: completed.
02
Drugs
teriparatide
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on 2009-011784-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-011784-37.